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In recent years several guidelines on the prevention 
and treatment of osteoporosis have been published. In 
the Netherlands two professional organisations have 
updated their earlier documents. The Dutch Institute 
for Healthcare Improvement, CBO, published its Second 
Revised Guideline on Osteoporosis in 2002.1 The Dutch 
College of General Practitioners (NHG) followed in 2005 
with a revised osteoporosis guideline.2 Both documents 
reflect the vast increase in knowledge on the diagnosis, 
epidemiology, prevention and treatment of osteoporosis in 
the past decades.
Bone densitometry, mostly by dual energy X-ray 
absorptiometry (DEXA), remains a cornerstone in the 
assessment of fracture risk and in the selection of patients 
for treatment with bone-active protective agents such as 
bisphosphonates. The two Dutch guidelines mentioned 
above are in accordance on the indication for bone 
densitometry. They recommend a DEXA is performed 
in selected individuals with increased fracture risk based 
on other risk factors. The risk score included in the NHG 
guideline is summarised in table 1. Bone densitometry is 
recommended for patients with a risk score ≥4.
In this issue of the Journal, Schurink et al. report on a 
study of osteoporosis case-finding that was performed 
between October 2003 and June 2004.3  They studied 
patients aged ≥50 years, who had sustained a non-vertebral 
fracture in 2001, three years before the study.3 Eventually 
88 out of 273 patients were included in the study. About 
half of these patients also had at least one other risk factor. 
Bone densitometry had already been performed prior to the 
study in only 12 patients. DEXA scans were carried out as 
part of the study in all 88 patients. Low T-scores below -2.5 
were found in 45 patients. These results confirm the high 
prevalence of osteoporosis in patients above the age of 50 
with a fracture. 
The results also suggest that the doctors caring for these 
patients did not employ an active strategy to detect patients 
at risk for osteoporosis, as recommended by the 2002 
revised CBO guideline. This is in accordance with the 
low frequency of osteoporosis treatment after fractures 
reported in the literature.4-8
The revised NHG guidelines were published after the 
present study was carried out. Table 1 shows that bone 
densitometry should have been considered for the female 
patients (69 out of 88) in the study by Schurink et al.3 
according to the NHG guideline. The present study 
does not allow any conclusions on adherence to the 
NHG guideline. The reported low adherence to other 
osteoporosis guidelines does not allow for optimism.4-8 
The authors compare their results with their experience in 
a Fracture and Osteoporosis outpatient clinic. They have 
previously reported a much higher guideline adherence 
in this setting, 75% of the patients at risk being examined 
for osteoporosis.9 They strongly advocate the idea that the 
physician who treats the fracture should be responsible 
for initiating osteoporosis screening and subsequent 
treatment if necessary. The NHG guideline (note 1) 
also states that the physician who detects and treats the 
fracture should ideally also be responsible for osteoporosis 
screening and initiating treatment.2 However, other 
roles with a more active part to be played by the general 
practitioner (GP) can be agreed upon depending on 
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Table 1. Indications for bone densitometry (DEXA is 
recommended for patients with total score ≥4)2
risk factor score sex 
Existing vertebral fracture a 4 Male and 
female
Use of oral glucocorticoids b
(for ≥3 months at a dose (prednisolone) 
≥7.5 mg/day)
4 Male and 
female
Fracture after age 50 4 Female
Age >70 years 2 Female
Age >60 years 1 Female
Hip fracture in first-degree relative 1 Female
Body weight <60 kg 1 Female
Serious immobility 1 Female
a preventive treatment indicated for patients with more than one 
vertebral fracture without bone densitometry; b preventive treatment 
indicated for patients with a dose (prednisolone) ≤15 mg/day.
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regional preferences.2 One of the reasons to consider such 
a role for the GP would be that the GP remains responsible 
for the continuation of preventive treatment and that 
compliance to osteoporosis treatment regimens started 
outside family practice can be quite low.10 An active part in 
initiating treatment could perhaps contribute to achieving 
higher levels of compliance of preventive treatment.
The reasons for low osteoporosis guideline adherence have 
not been studied extensively. Solomon et al. found that 
patient age ≥75 or <55 years, male sex and the presence 
of more than one comorbid condition adversely affected 
guideline adherence. Female doctors followed osteoporosis 
guidelines more often than male doctors.11 More studies are 
needed to more fully comprehend the factors that influence 
guideline adherence in order to design appropriate 
implementation strategies. In the meantime, regional 
agreements should be reached between GPs, surgeons and 
other involved medical specialists on how to diagnose and 
treat osteoporosis in patients with a low-energy fracture 
after the age of 50. These agreements should be based 
on the current guidelines and include statements on the 
specific roles of all parties in the evaluation of patients, 
the initiation and continuation of therapy and on the 
communication between GPs and medical specialists. 
The agreements should also provide a means of evaluating 
practice and quality of care.
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